FDA Says Rx-To-OTC Proposal May Cut Costs, Boost Options For Patients

By Beth Wang / June 27, 2022 at 6:06 PM
FDA on Monday (June 27) proposed a highly anticipated rule that would make it easier to switch prescription drugs to over-the-counter status as long as consumers can appropriately self-select and use the drug without the supervision of a health care professional. The proposal is a key part of the Biden administration’s efforts to lower health care costs, HHS says. Lawmakers and the OTC industry have waited years for the proposed rule, “Nonprescription Drug Product With an Additional Condition for Nonprescription...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.